Methyl 2-azabicyclo[2.2.2]octane-4-carboxylate hydrochloride, 98%, 5g

2-(6-Bromo-2,3-difluorophenyl)acetonitrile, 98%, 250mg

trans-4-(N-Maleimidomethyl)cyclohexane-1-carboxylic Acid>98.0%(GC)1g

1-Boc-4-(2-Methoxyethylamino)piperidine, 95.0%, 250mg

Co 102862, 25mg

Bismuth ICP standard solution, ROTI®Star, 10000 mg/l Bi, density (D) ~1 g/cm³

1H-indazol-6-amine, 95%, 1g

(5R,5aR,8aR,9R)-9-Hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one, 97.0%, 10mg

4-(5-Methyl-1,3,4-oxadiazol-2-yl)aniline, 95.0%, 1g

(S)-3-Amino-3-(2-bromophenyl)propanoic acid, 95.0%, 1g

[2,2':6',2''-terpyridine]-4'-carbaldehyde, 97%, 1g

5-Bromo-4-fluoropyridin-2(1H)-one, 97%, 5g

Sodium (Z)-5-(2-carbamoylhydrazono)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate, 95.0%, 1g